\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ neurological\\ exam\ \(3\)\
\-\ main\\ blood\\ supply\\ for\\ this\\ tumor\\ was\\ a\\ branch\\ from\\ the\\ middle\\ meningeal\\ artery\\,\\ which\\ was\\ endovascularly\\ embolized\\ with\\ polyvinyl\\ alcohol\\ particles\\ \\(pva\\)\\ at\\ the\\ time\\ the\\ angiogram\\ was\\ performed\\.\\ the\\ tumor\\ was\\ then\\ resected\\ surgically\\.\ \(0\)\
\-\ on\\ mri\\,\\ there\\ is\\ a\\ 6\\ cm\\ extra\\-axial\\ mass\\ arising\\ from\\ the\\ greater\\ wing\\ of\\ the\\ right\\ sphenoid\\ bone\\.\\ there\\ is\\ hyperostosis\\ at\\ the\\ attachment\\ point\\ of\\ the\\ mass\\ to\\ the\\ sphenoid\\ bone\\ and\\ multiple\\ vascular\\ flow\\-voids\ \(0\)\
\-\ course\\ into\\ the\\ mass\\ from\\ the\\ position\\ of\\ attachment\\.\\ there\\ is\\ a\\ small\\ dural\\ tail\\ at\\ the\\ point\\ of\\ attachment\\ of\\ the\\ mass\\.\\ the\\ mass\\ is\\ predominantly\\ isointense\\ to\\ brain\\ cortex\\ on\\ all\\ pulse\\ sequences\\ and\\ enhances\\ densely\\.\\ mass\\ produces\\ significant\\ mass\\-effect\\ on\\ adjacent\\ right\\ frontal\\ lobe\\,\\ right\\ insula\\,\\ right\\ temporal\\ lobe\\,\\ and\\ anterior\\ right\\ parietal\\ lobe\\.\\ an\\ area\\ of\\ t2\\ signal\\ is\\ seen\\ medial\\ to\\ the\\ tumor\\&\\#39\\;s\\ margins\\ may\\ indicate\\ pial\\ involvement\\.\ \(0\)\
\-\ on\\ the\\ cerebral\\ angiogram\\,\\ there\\ is\\ a\\ very\\ large\\ hypervascular\\ extra\\-axial\\ mass\\ that\\ is\\ supplied\\ predominantly\\ by\\ multiple\\ dural\\ branches\\ arising\\ from\\ the\\ frontal\\ branch\\ of\\ the\\ right\\ middle\\ meningeal\\ artery\\ off\\ the\\ right\\ eca\\.\\ however\\,\\ a\\ small\\ area\\ of\\ tumor\\ blush\\ is\\ demonstrated\\ on\\ the\\ angiogram\\ of\\ the\\ right\\ ica\\.\\ this\\ is\\ because\\ the\\ tumor\\ has\\ acquired\\ additional\\ blood\\ supply\\ from\\ mca\\ branches\\ which\\ are\\ pial\\ arteries\\ and\\ additional\\ venous\\ drainage\\ to\\ cortical\\ \\(pial\\)\\ veins\\ by\\ invading\\ the\\ pia\\.\\ delayed\\ angiogram\\ images\\ also\\ demonstrate\\ classic\\ \\"mother\\-in\\-law\\"\\ effect\\ of\\ contrast\\ coming\\ early\\ and\\ staying\\ late\\.\ \(0\)\
\-\ meningioma\\ with\\ pial\\ invasion\ \(0\)\
\-\ dural\\ based\\ mass\\:\ \(0\)\
\-\ \\ \\â\\€\\¢\\ meningioma\ \(0\)\
\-\ \\ \\â\\€\\¢\\ hemangiopericytoma\ \(0\)\
\-\ \\ \\â\\€\\¢\\ dural\\ metastasis\\ \\(in\\ a\\ woman\\,\\ breast\\ cancer\\)\ \(0\)\
\-\ \\ \\â\\€\\¢\\ sarcoid\\ and\\ other\\ granulomatous\\ disease\ \(0\)\
\-\ 30\\ y\\.o\\.\\ woman\\ with\\ new\\ onset\\ seizures\\ and\\ syncope\ \(1\)\
\-\ meningiomas\\ are\\ the\\ most\\ common\\ extra\\-axial\\ neoplasm\\ in\\ the\\ brain\\.\\ patients\\ are\\ most\\ commonly\\ middle\\-aged\\ and\\ female\\ more\\ often\\ than\\ male\\.\\ 90\\%\\ are\\ supratentorial\\ and\\ occur\\ most\\ often\\ along\\ the\\ parasagittal\\ dura\\,\\ convexities\\,\\ sphenoid\\ wing\\ and\\ cerebellopontine\\ angle\\.\\ \ \(0\)\
\-\ on\\ ct\\,\\ the\\ majority\\ are\\ slightly\\ hyperdense\\.\\ on\\ mri\\,\\ they\\ are\\ most\\ often\\ isointense\\ on\\ t1\\ and\\ t2\\ sequences\\,\\ but\\ may\\ be\\ slightly\\ hypointense\\ on\\ t1\\ or\\ slightly\\ hyperintense\\ on\\ t2\\.\\ vascular\\ flow\\ voids\\ can\\ be\\ present\\ within\\ or\\ around\\ these\\ masses\\.\\ up\\ to\\ 70\\%\\ of\\ cases\\ have\\ a\\ dural\\ tail\\ seen\\ at\\ the\\ edges\\ of\\ the\\ lesion\\.\\ meningiomas\\ also\\ uniformly\\ enhance\\ after\\ contrast\\ administration\\.\\ associated\\ edema\\ in\\ the\\ adjacent\\ brain\\ can\\ be\\ seen\\.\\ changes\\ in\\ adjacent\\ bone\\ can\\ be\\ seen\\,\\ including\\ hyperostosis\\ or\\ osteolysis\\.\\ \ \(0\)\
\-\ angiography\\ is\\ rarely\\ performed\\ for\\ diagnosis\\ of\\ meningioma\\,\\ but\\ rather\\ is\\ peformed\\ as\\ part\\ of\\ a\\ preoperative\\ endovascular\\ embolization\\ procedure\\.\\ at\\ angiography\\,\\ a\\ tumor\\ blush\\ is\\ seen\\.\\ classically\\ meningiomas\\ enhance\\ early\\ in\\ the\\ arterial\\ phase\\ of\\ the\\ angiogram\\ and\\ enhancement\\ remains\\ in\\ the\\ late\\ venous\\ phase\\.\\ often\\ the\\ middle\\ meningeal\\ artery\\ is\\ enlarged\\,\\ particularly\\ if\\ the\\ tumor\\ is\\ located\\ along\\ a\\ convexity\\ or\\ the\\ sphenoid\\ wings\\.\\ preoperative\\ endovascular\\ embolization\\ can\\ be\\ performed\\ to\\ decrease\\ intraoperative\\ blood\\ loss\\.\\ \ \(0\)\
\-\ meningiomas\\ are\\ usually\\ who\\ grade\\ i\\ tumors\\.\\ however\\ other\\ subtypes\\ include\\ atypical\\ meningiomas\\ \\(2\\.4\\%\\ of\\ meningiomas\\)\\ which\\ are\\ who\\ grade\\ ii\\,\\ and\\ malignant\\ meningiomas\\ \\(rare\\)\\ which\\ are\\ who\\ grade\\ iii\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ meningiomas\\:\\ 0\\.3240069535039057\ \(0\)\
\-\ the\\:\\ 0\\.2839226886191201\ \(0\)\
\-\ pial\\:\\ 0\\.20823163590625982\ \(0\)\
\-\ angiogram\\:\\ 0\\.1775312305949976\ \(0\)\
\-\ dural\\:\\ 0\\.17537485551109463\ \(0\)\
\-\ sphenoid\\:\\ 0\\.15903727800194833\ \(0\)\
\-\ is\\:\\ 0\\.1515400341696684\ \(0\)\
\-\ tumor\\:\\ 0\\.1447183927547178\ \(0\)\
\-\ mass\\:\\ 0\\.1358786887147094\ \(0\)\
\-\ are\\:\\ 0\\.1349826859547713\ \(0\)\
\-\ meningeal\\:\\ 0\\.1333369760871775\ \(0\)\
\-\ attachment\\:\\ 0\\.13073522154666326\ \(0\)\
\-\ of\\:\\ 0\\.12375900559441431\ \(0\)\
\-\ on\\:\\ 0\\.11937336923065979\ \(0\)\
\-\ middle\\:\\ 0\\.11305567499130965\ \(0\)\
\-\ and\\:\\ 0\\.10617661045364993\ \(0\)\
\-\ right\\:\\ 0\\.10483433578098487\ \(0\)\
\-\ often\\:\\ 0\\.10316117758278874\ \(0\)\
\-\ blush\\:\\ 0\\.09849690777907984\ \(0\)\
\-\ seen\\:\\ 0\\.09304109543272154\ \(0\)\
\-\ slightly\\:\\ 0\\.09249530648858442\ \(0\)\
\-\ hyperostosis\\:\\ 0\\.09087439995557019\ \(0\)\
\-\ meningioma\\:\\ 0\\.08885162100206741\ \(0\)\
\-\ endovascular\\:\\ 0\\.0875705148654543\ \(0\)\
\-\ wing\\:\\ 0\\.08598502335608926\ \(0\)\
\-\ preoperative\\:\\ 0\\.08598502335608926\ \(0\)\
\-\ grade\\:\\ 0\\.08526651862586634\ \(0\)\
\-\ can\\:\\ 0\\.08296662535881494\ \(0\)\
\-\ most\\:\\ 0\\.08228077526793011\ \(0\)\
\-\ voids\\:\\ 0\\.08100484087032088\ \(0\)\
\-\ be\\:\\ 0\\.08016929046643004\ \(0\)\
\-\ supply\\:\\ 0\\.07951863900097417\ \(0\)\
\-\ from\\:\\ 0\\.0784889848833609\ \(0\)\
\-\ branches\\:\\ 0\\.07839135620400291\ \(0\)\
\-\ tail\\:\\ 0\\.07796492447782613\ \(0\)\
\-\ branch\\:\\ 0\\.07755122397681401\ \(0\)\
\-\ adjacent\\:\\ 0\\.07686103383647457\ \(0\)\
\-\ at\\:\\ 0\\.07464614275590344\ \(0\)\
\-\ late\\:\\ 0\\.0746229157388602\ \(0\)\
\-\ brain\\:\\ 0\\.07392001363795307\ \(0\)\
\-\ artery\\:\\ 0\\.07364364044051835\ \(0\)\
\-\ angiography\\:\\ 0\\.07306420286124245\ \(0\)\
\-\ which\\:\\ 0\\.07189029636481328\ \(0\)\
\-\ isointense\\:\\ 0\\.0715306063251027\ \(0\)\
\-\ enhance\\:\\ 0\\.07076052279441103\ \(0\)\
\-\ performed\\:\\ 0\\.07014999476246908\ \(0\)\
\-\ predominantly\\:\\ 0\\.06922573729704048\ \(0\)\
\-\ embolization\\:\\ 0\\.06889445608034903\ \(0\)\
\-\ blood\\:\\ 0\\.06886445960512874\ \(0\)\
\-\ in\\:\\ 0\\.06882838627477345\ \(0\)\
\-\ lobe\\:\\ 0\\.06852444314577953\ \(0\)\
\-\ t2\\:\\ 0\\.06822009061615092\ \(0\)\
\-\ phase\\:\\ 0\\.06764326659152764\ \(0\)\
\-\ who\\:\\ 0\\.06707394966125566\ \(0\)\
\-\ point\\:\\ 0\\.06535126771773811\ \(0\)\
\-\ bone\\:\\ 0\\.06469880373177538\ \(0\)\
\-\ sequences\\:\\ 0\\.06323922101625516\ \(0\)\
\-\ pva\\:\\ 0\\.06320965407107186\ \(0\)\
\-\ there\\:\\ 0\\.0629080710540187\ \(0\)\
\-\ arising\\:\\ 0\\.06281059083879797\ \(0\)\
\-\ additional\\:\\ 0\\.06128034446286238\ \(0\)\
\-\ endovascularly\\:\\ 0\\.06040019898404683\ \(0\)\
\-\ peformed\\:\\ 0\\.06040019898404683\ \(0\)\
\-\ to\\:\\ 0\\.05928757297548809\ \(0\)\
\-\ polyvinyl\\:\\ 0\\.05840685887725778\ \(0\)\
\-\ staying\\:\\ 0\\.05840685887725778\ \(0\)\
\-\ early\\:\\ 0\\.056982236814809684\ \(0\)\
\-\ venous\\:\\ 0\\.05643871861863563\ \(0\)\
\-\ pia\\:\\ 0\\.05559740379023275\ \(0\)\
\-\ effect\\:\\ 0\\.05545304032240178\ \(0\)\
\-\ was\\:\\ 0\\.05509991601507253\ \(0\)\
\-\ or\\:\\ 0\\.05500067466093708\ \(0\)\
\-\ wings\\:\\ 0\\.05452929853789738\ \(0\)\
\-\ particles\\:\\ 0\\.053604063683443705\ \(0\)\
\-\ eca\\:\\ 0\\.053604063683443705\ \(0\)\
\-\ along\\:\\ 0\\.05296095499120235\ \(0\)\
\-\ insula\\:\\ 0\\.05278794870320771\ \(0\)\
\-\ parasagittal\\:\\ 0\\.05278794870320771\ \(0\)\
\-\ flow\\:\\ 0\\.052653367916352445\ \(0\)\
\-\ vascular\\:\\ 0\\.0521880697074364\ \(0\)\
\-\ convexities\\:\\ 0\\.052057908976564954\ \(0\)\
\-\ area\\:\\ 0\\.05121019870020739\ \(0\)\
\-\ frontal\\:\\ 0\\.05087915730453399\ \(0\)\
\-\ t1\\:\\ 0\\.04925353737882461\ \(0\)\
\-\ densely\\:\\ 0\\.04924845388953992\ \(0\)\
\-\ coming\\:\\ 0\\.04924845388953992\ \(0\)\
\-\ uniformly\\:\\ 0\\.04880126848962962\ \(0\)\
\-\ osteolysis\\:\\ 0\\.048381202376035166\ \(0\)\
\-\ however\\:\\ 0\\.04678878279279146\ \(0\)\
\-\ syncope\\:\\ 0\\.04659471251975218\ \(0\)\
\-\ subtypes\\:\\ 0\\.04659471251975218\ \(0\)\
\-\ supplied\\:\\ 0\\.0462867076434151\ \(0\)\
\-\ invading\\:\\ 0\\.04599181340260458\ \(0\)\
\-\ embolized\\:\\ 0\\.04570895907587213\ \(0\)\
\-\ edges\\:\\ 0\\.04570895907587213\ \(0\)\
\-\ intraoperative\\:\\ 0\\.04570895907587213\ \(0\)\
\-\ supratentorial\\:\\ 0\\.04492370815026921\ \(0\)\
\-\ cerebellopontine\\:\\ 0\\.044218459036148405\ \(0\)\
\-\ produces\\:\\ 0\\.04337755344339047\ \(0\)\
\-\ convexity\\:\\ 0\\.04337755344339047\ \(0\)\
\-\ dura\\:\\ 0\\.04299251167804463\ \(0\)\
\-\ hemangiopericytoma\\:\\ 0\\.04195121098063996\ \(0\)\
\-\ hypervascular\\:\\ 0\\.0417919173259381\ \(0\)\
\-\ ica\\:\\ 0\\.041334896624435305\ \(0\)\
\-\ classically\\:\\ 0\\.041334896624435305\ \(0\)\
\-\ woman\\:\\ 0\\.041169872618741395\ \(0\)\
\-\ other\\:\\ 0\\.041052307225469764\ \(0\)\
\-\ mca\\:\\ 0\\.04090616388205804\ \(0\)\
\-\ small\\:\\ 0\\.04077702288354666\ \(0\)\
\-\ mri\\:\\ 0\\.040577624657547474\ \(0\)\
\-\ indicate\\:\\ 0\\.04024576261905936\ \(0\)\
\-\ may\\:\\ 0\\.039780814141489165\ \(0\)\
\-\ but\\:\\ 0\\.03909070378553115\ \(0\)\
\-\ multiple\\:\\ 0\\.03866542683937396\ \(0\)\
\-\ contrast\\:\\ 0\\.038409130066948766\ \(0\)\
\-\ acquired\\:\\ 0\\.038096708795033005\ \(0\)\
\-\ remains\\:\\ 0\\.03764952339512271\ \(0\)\
\-\ pulse\\:\\ 0\\.0373114578694301\ \(0\)\
\-\ particularly\\:\\ 0\\.0373114578694301\ \(0\)\
\-\ also\\:\\ 0\\.037183192405163296\ \(0\)\
\-\ sarcoid\\:\\ 0\\.03706831120900798\ \(0\)\
\-\ surgically\\:\\ 0\\.03668111725578694\ \(0\)\
\-\ alcohol\\:\\ 0\\.036532101430621224\ \(0\)\
\-\ hyperdense\\:\\ 0\\.036386223014976425\ \(0\)\
\-\ resected\\:\\ 0\\.03617300715188803\ \(0\)\
\-\ majority\\:\\ 0\\.03589855666949506\ \(0\)\
\-\ part\\:\\ 0\\.03531811776264105\ \(0\)\
\-\ invasion\\:\\ 0\\.03525652652324637\ \(0\)\
\-\ rarely\\:\\ 0\\.03525652652324637\ \(0\)\
\-\ granulomatous\\:\\ 0\\.03513496254890819\ \(0\)\
\-\ veins\\:\\ 0\\.035074971102218924\ \(0\)\
\-\ rather\\:\\ 0\\.03501549460992094\ \(0\)\
\-\ enhances\\:\\ 0\\.034840068308097674\ \(0\)\
\-\ hypointense\\:\\ 0\\.034782566162246585\ \(0\)\
\-\ angle\\:\\ 0\\.0346689739656581\ \(0\)\
\-\ main\\:\\ 0\\.03444722804017451\ \(0\)\
\-\ iii\\:\\ 0\\.03412737269265992\ \(0\)\
\-\ decrease\\:\\ 0\\.03397281679459292\ \(0\)\
\-\ margins\\:\\ 0\\.033722646343596195\ \(0\)\
\-\ by\\:\\ 0\\.03356951977615688\ \(0\)\
\-\ off\\:\\ 0\\.033022154503131895\ \(0\)\
\-\ 39\\:\\ 0\\.03284672820130863\ \(0\)\
\-\ 70\\:\\ 0\\.03263351233822024\ \(0\)\
\-\ arterial\\:\\ 0\\.032550029776447165\ \(0\)\
\-\ neurological\\:\\ 0\\.0324675410783124\ \(0\)\
\-\ atypical\\:\\ 0\\.03242666208771417\ \(0\)\
\-\ seizures\\:\\ 0\\.03226551601519389\ \(0\)\
\-\ cortex\\:\\ 0\\.03218632693830994\ \(0\)\
\-\ parietal\\:\\ 0\\.03191608220342607\ \(0\)\
\-\ drainage\\:\\ 0\\.0316559831313275\ \(0\)\
\-\ 90\\:\\ 0\\.03158342782116234\ \(0\)\
\-\ around\\:\\ 0\\.031547433097054906\ \(0\)\
\-\ position\\:\\ 0\\.03151162439302369\ \(0\)\
\-\ procedure\\:\\ 0\\.03151162439302369\ \(0\)\
\-\ administration\\:\\ 0\\.031475999796253144\ \(0\)\
\-\ hyperintense\\:\\ 0\\.03144055742328065\ \(0\)\
\-\ arteries\\:\\ 0\\.031370211958073956\ \(0\)\
\-\ located\\:\\ 0\\.03126601497486868\ \(0\)\
\-\ ii\\:\\ 0\\.031163361707567883\ \(0\)\
\-\ delayed\\:\\ 0\\.030929591190401274\ \(0\)\
\-\ temporal\\:\\ 0\\.0303623589880848\ \(0\)\
\-\ rare\\:\\ 0\\.02983806932636172\ \(0\)\
\-\ classic\\:\\ 0\\.029563074156537566\ \(0\)\
\-\ commonly\\:\\ 0\\.02924686862294774\ \(0\)\
\-\ course\\:\\ 0\\.029195542693382478\ \(0\)\
\-\ greater\\:\\ 0\\.029119259697490893\ \(0\)\
\-\ occur\\:\\ 0\\.02906886697494782\ \(0\)\
\-\ tumors\\:\\ 0\\.02906886697494782\ \(0\)\
\-\ metastasis\\:\\ 0\\.02896916786194822\ \(0\)\
\-\ breast\\:\\ 0\\.028702169305998657\ \(0\)\
\-\ based\\:\\ 0\\.028631102336255612\ \(0\)\
\-\ involvement\\:\\ 0\\.02860757440598017\ \(0\)\
\-\ cortical\\:\\ 0\\.028376587389758283\ \(0\)\
\-\ very\\:\\ 0\\.028353906620542848\ \(0\)\
\-\ including\\:\\ 0\\.028286306388655945\ \(0\)\
\-\ they\\:\\ 0\\.02824160320902656\ \(0\)\
\-\ malignant\\:\\ 0\\.02817508459759868\ \(0\)\
\-\ then\\:\\ 0\\.027979276530797712\ \(0\)\
\-\ because\\:\\ 0\\.02762386689390009\ \(0\)\
\-\ cerebral\\:\\ 0\\.027383531744495856\ \(0\)\
\-\ new\\:\\ 0\\.027344274025833882\ \(0\)\
\-\ this\\:\\ 0\\.027163250435331545\ \(0\)\
\-\ neoplasm\\:\\ 0\\.026982017097963325\ \(0\)\
\-\ 30\\:\\ 0\\.026963465630901403\ \(0\)\
\-\ enlarged\\:\\ 0\\.026944963700526098\ \(0\)\
\-\ masses\\:\\ 0\\.026908107396560323\ \(0\)\
\-\ cases\\:\\ 0\\.02658493629017631\ \(0\)\
\-\ cancer\\:\\ 0\\.026326683958176222\ \(0\)\
\-\ medial\\:\\ 0\\.025728011110637244\ \(0\)\
\-\ onset\\:\\ 0\\.02538035633611432\ \(0\)\
\-\ usually\\:\\ 0\\.024882678061620984\ \(0\)\
\-\ demonstrated\\:\\ 0\\.02429122233073836\ \(0\)\
\-\ loss\\:\\ 0\\.02408029741454091\ \(0\)\
\-\ for\\:\\ 0\\.023959666063585988\ \(0\)\
\-\ changes\\:\\ 0\\.023887478883840765\ \(0\)\
\-\ edema\\:\\ 0\\.0235737921959442\ \(0\)\
\-\ all\\:\\ 0\\.02352850465689187\ \(0\)\
\-\ include\\:\\ 0\\.023517228871151187\ \(0\)\
\-\ time\\:\\ 0\\.02342767713923079\ \(0\)\
\-\ with\\:\\ 0\\.02321867841951878\ \(0\)\
\-\ if\\:\\ 0\\.02296521592255232\ \(0\)\
\-\ significant\\:\\ 0\\.02282107170008601\ \(0\)\
\-\ enhancement\\:\\ 0\\.022750108707245684\ \(0\)\
\-\ cm\\:\\ 0\\.022699862157769615\ \(0\)\
\-\ common\\:\\ 0\\.022415405942506496\ \(0\)\
\-\ signal\\:\\ 0\\.022405802380596956\ \(0\)\
\-\ than\\:\\ 0\\.022405802380596956\ \(0\)\
\-\ these\\:\\ 0\\.02231996409178918\ \(0\)\
\-\ patients\\:\\ 0\\.022235176195909562\ \(0\)\
\-\ anterior\\:\\ 0\\.02206865090659204\ \(0\)\
\-\ more\\:\\ 0\\.02170364973558453\ \(0\)\
\-\ into\\:\\ 0\\.021011000531847172\ \(0\)\
\-\ associated\\:\\ 0\\.020832828297321186\ \(0\)\
\-\ demonstrate\\:\\ 0\\.02054813872523075\ \(0\)\
\-\ diagnosis\\:\\ 0\\.020489666067604353\ \(0\)\
\-\ present\\:\\ 0\\.020281745557321283\ \(0\)\
\-\ exam\\:\\ 0\\.019897085595414414\ \(0\)\
\-\ large\\:\\ 0\\.01980416699671322\ \(0\)\
\-\ have\\:\\ 0\\.019745084953025367\ \(0\)\
\-\ up\\:\\ 0\\.019551705830678525\ \(0\)\
\-\ after\\:\\ 0\\.019174399688449213\ \(0\)\
\-\ female\\:\\ 0\\.019072808847688305\ \(0\)\
\-\ lesion\\:\\ 0\\.018949336471458363\ \(0\)\
\-\ images\\:\\ 0\\.01828311009772692\ \(0\)\
\-\ within\\:\\ 0\\.01820416163092402\ \(0\)\
\-\ has\\:\\ 0\\.018054032414338415\ \(0\)\
\-\ male\\:\\ 0\\.017598210392677473\ \(0\)\
\-\ that\\:\\ 0\\.017152523634236954\ \(0\)\
\-\ disease\\:\\ 0\\.016591341646752068\ \(0\)\
\-\ normal\\:\\ 0\\.01613793913668171\ \(0\)\
\-\ as\\:\\ 0\\.01587873956427925\ \(0\)\
\-\ an\\:\\ 0\\.015114364685487467\ \(0\)\
\-\ ct\\:\\ 0\\.015047675346726613\ \(0\)\
